SkinHealth Systems (SKIN) Net Income towards Common Stockholders (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$6.6 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 34.33% year-over-year to -$6.6 million in Q1 2026; TTM through Mar 2026 was -$6.1 million, a 84.26% increase from a year earlier, with the FY2025 full-year figure at -$9.5 million, up 67.29% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$6.6 million, up from -$8.1 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for SKIN reached as high as $31.5 million in Q1 2022 and fell as low as -$73.8 million in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged -$5.9 million across 5 years, with a median of -$6.6 million in 2026.
• Across the five-year window, Net Income towards Common Stockholders tumbled 72270.59% in 2023 and soared 7819.28% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $6.6 million in 2022, then plunged by 243.27% to -$9.4 million in 2023, then retreated by 10.24% to -$10.4 million in 2024, then rose by 21.82% to -$8.1 million in 2025, then climbed by 18.19% to -$6.6 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$6.6 million in Q1 2026, -$8.1 million in Q4 2025, and -$11.0 million in Q3 2025.